Skip to content

PAtient NOtifier Feature for Reduction of Anxiety

PAtient NOtifier Feature for Reduction of Anxiety: A Multicenter ICD Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00559559
Acronym
Panoramic
Enrollment
362
Registered
2007-11-16
Start date
2007-12-31
Completion date
2010-12-31
Last updated
2019-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tachycardia, Ventricular

Keywords

Primary and secondary prevention for ventricular tachycardia

Brief summary

This study is intended to look at the effect of the SJM vibrating Patient Notifier™ system, which will warn the patient of possible failures of the implanted system, on reducing patient device related anxiety

Interventions

DEVICEICD implant + Patient Notifier turned OFF

ICD implant, plus standard care, i.e. Patient Notifier turned off

PROCEDUREICD Implant + Patient Notifier turned ON

ICD implant. The Patient Notifier™ feature will be turned ON.

Sponsors

Abbott Medical Devices
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient has recently (min. 2 weeks - max. 14 weeks) been implanted with an SJM ICD with the Patient Notifier™ feature; * Patient is willing and able to independently comprehend and complete the study-related questionnaires; * Patient has signed the study specific informed consent form.

Exclusion criteria

* have already had a Patient Notifier™ alert since implant; * had a prior device implant (PM or ICD); * have not been discharged from the hospital since device implant; * have evidence of psychosis, dementia or cognitive impairment as documented in the patients' hospital records; * cannot commit to the follow-up schedule; * have a life expectancy of less than 1 year; * are on a waiting list for a heart transplant; * are less than 18 years old; * are pregnant;

Design outcomes

Primary

MeasureTime frame
Reduction in device related anxiety, related to battery depletion, as assessed by the Duru Questionnaire (question 9) Reduction in device related anxiety, related to device malfunction, as assessed by the Duru Questionnaire (question 10)12months

Secondary

MeasureTime frame
Reduction in general anxiety Evolution over time in anxiety for the different personality types Cross-overs Sensitivity and Specificity of the Patient Notifier™ Number of appropriate/inappropriate ICD therapies Hospitalizations Mortality1year

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 1, 2026